In Beech Tree Labs’ efforts to get its products to those that need them, the company has created two spinoffs to address specific challenges.

1. Resolys Bio, Inc. was created to focus on BTL’s product for the treatment of scar-associated disorders such as traumatic brain injury, adhesions, and complications from surgery. Visit www.resolysbio.com.

2. For several of its older products that have gone through extensive evaluation, BTL created a second spinoff, Molecular Signals, Inc. to develop these products in an over-the-counter format. Visit www.signalshealth.co.